We investigated whether red cell 2, concentrations are reduced in critical illness, whether acidaemia, hypophosphataemia or anaemia influence 2,3-DPG, and whether there is any net effect on in vivo P50.
There have been a number of investigations into whether haemoglobin-oxygen affinity is increased, normal or decreased in critical illness, but the data thus far have been inconclusive and conflicting [1] [2] [3] [4] [5] . The answer to this question may be important, since factors affecting binding of oxygen to haemoglobin influence tissue oxygenation in low perfusion states [6] [7] [8] [9] [10] [11] and possibly also in severe hypoxaemic respiratory failure with right-to-left shunting 12 .
The shorthand quantification of haemoglobin-oxygen affinity is the P50, which is the oxygen tension at which haemoglobin is 50% saturated with oxygen. One reason for the uncertainty of previous studies may have been that P50 values were calculated for standard conditions of pH, PCO 2 and temperature (the standard P50). Standard P50 only quantifies in vivo haemoglobin-oxygen affinity accurately when there are no acid-base or temperature disturbances, which is rarely the case in critical illness. For correct quantification of in vivo haemoglobin-oxygen affinity, the in vivo P50 is mandatory. The in vivo P50 is the oxygen tension at which haemoglobin is 50% saturated with oxygen at the temperature and acidbase status of the blood of the patient 13 . A second deficiency in most previous investigations has been the failure to measure 2,3-DPG concentrations. Myburgh and coworkers 4 compared a group of critically ill patients with healthy controls and found the mean standard P50 to be significantly reduced in the patient group. Although the authors speculated on the possibility of reduced 2,3-DPG concentrations, no measurements were made. In a similar investigation by Huang and coworkers 5 , patients with ARDS were shown to have a reduced mean standard P50 when compared with normal controls. The authors were unable to suggest a cause for this reduction. In both studies reduced 2,3-DPG was a possible explanation.
To our knowledge, there have been only two studies in which 2,3-DPG concentrations were measured in critical illness. The findings of these studies differed considerably, although in neither case was there a systematic reduction in 2,3-DPG concentrations. McConn 2 , whose investigation was published 30 years ago, found no consistent trend in measured 2,3-DPG concentrations or in standard P50 values. Importantly, no in vivo P50 values were reported. Recently Clerbaux and coworkers 3 reported significant elevations both of the standard P50 and 2,3-DPG concentrations in a group of patients suffering from acute respiratory distress syndrome (ARDS) compared with healthy controls. The patients were severely hypoxaemic (mean P a O 2 reported as 5.73 kPa (43 mmHg)) and had a tendency to alkalaemia (mean pH 7.44). As in all other studies, no in vivo P50 values were reported.
We therefore re-evaluated the status of 2,3-DPG concentrations and haemoglobin-oxygen affinity in a representative group of critically ill patients using the APACHE 2 severity of illness classification 14 as the sole enrolment criterion. For reasons already outlined, the in vivo P50 was chosen as the appropriate and clinically relevant quantification of haemoglobinoxygen affinity. We first compared the mean venous 2,3-DPG concentration of these patients with that of a group of healthy controls. We then examined the patient group in more detail to determine both the relationship between 2,3-DPG concentrations and three of its principle determinants (pH, serum phosphate concentrations, haemoglobin concentrations) 15 , and the correlation between 2,3-DPG concentrations and in vivo P50 values.
MATERIALS AND METHODS
The Institutional Review Board approved the protocol and waived the need for informed consent. Two groups of males were studied. Group 1 (Controls) included 20 healthy non-smoking volunteers drawn from the nursing and medical staff. Group 2 (Patients) consisted of 20 intensive care patients with APACHE 2 scores calculated as >20 using data from the preceding calendar day. Consecutive eligible patients were studied where possible. Those who had received blood transfusions in the preceding 24 hours were excluded.
Group 1: Controls
After collection of venous blood, portions for 2,3-DPG assay were placed on ice in vacuum collection tubes containing lithium heparin, and portions for haematocrit measurement were placed in tubes containing ethylenediamine tetra-acetic acid. Specimens for 2,3-DPG assay were immediately deproteinized by addition of three volumes of 8% trichloroacetic acid, and then centrifuged at 3000 rpm for 10 minutes. The supernatant was frozen at -20°C for later 2,3-DPG analysis.
Group 2: Patients
After collection of venous blood for routine coagulation studies, remaining blood (normally discarded) was prepared for 2,3-DPG assay as in Group 1. Collection of morning arterial blood specimens proceeded as normal, with routine submission of portions for blood gas analysis, multichannel biochemical profile and automated full blood count. The bladder or rectal core temperature (or the axillary temperature if the core temperature was unavailable) was noted at the time of blood collection as well as one hour before and one hour after collection. The mean of these three values was then calculated.
2,3-DPG assay
A commercially available enzymatic kit was used (Sigma Diagnostics, St Louis, MO, U.S.A.). The endpoint of the assay was the formation of nicotinamide adenine dinucleotide, which was quantified by a decrease in spectrophotometric absorbance at 340 nm. Erythrocytic 2,3-DPG concentrations were calculated from the measured blood 2,3-DPG concentrations as follows:
Calculation of in vivo P50 values P50 values for arterial blood were calculated using the Oxygen Status Algorithm of Siggaard-Andersen 16 , with the input variables consisting of arterial pH, arterial PCO 2 (mmHg), arterial carboxyhaemoglobin concentration (%), arterial methaemoglobin concentration (%), mean core temperature (°C) and measured venous [2,3-DPG ] (mmol/l).
Data analysis
All variables were found to follow approximately normal distributions, and thus standard parametric techniques were used for all analyses. Mean 2,3-DPG concentrations in patients and controls were compared using independent-sample t-tests assuming unequal variances. In the patient group, the independent influences of arterial pH, serum phosphate concentrations and haemoglobin concentrations on 2,3-DPG concentrations were determined by multivariate linear regression. The degree of independent association for each of pH, phosphate and haemoglobin on 2,3-DPG was assessed using partial correlation coefficients (r). The relationship between patient in vivo P50 values and 2,3-DPG concentrations was analysed using simple linear regression. Significance was accepted at P<0.05. Unless otherwise indicated, data are expressed as mean±SD. Statistical analyses were done using SPSS for Windows version 10.0 (SPSS Inc. Chicago, Ill, U.S.A.).
RESULTS

Comparison of 2,3-DPG concentrations; patients versus controls
The mean 2,3-DPG concentration in the patient group was significantly lower than in the control group (4.2±1.3 mmol/l versus 4.9±0.5 mmol/l, P=0.016).
Characteristics of patients
Patient diagnoses and ICU outcomes are set out in Table 1 . ICU mortality was 30%. The median arterial PO 2 at the time of blood collection was 92 mmHg (range 75 to 131 mmHg). No patient had been subjected to hypoxaemia in the preceding 24 hours. There was a slight tendency to acidaemia (median arterial pH 7.37, range 7.06 to 7.48), and anaemia (median haemoglobin concentration 113 g/l, range 89 to 154 g/l). Median serum phosphate concentration was 1.01 mmol/l (range 0.38 to 4.24 mmol/l). Only six of the 20 serum phosphate values were outside the laboratory reference range (0.8 to 1.5 mmol/l), and only three of these values were markedly abnormal. Mean core temperature was 37.8±1.1°C. Mean in vivo P50 was 28.0±1.3 mmHg (and 26.4±2.6 mmHg without temperature correction).
Influence of three determinants on patient 2,3-DPG concentrations
Using multiple linear regression with 2,3-DPG as the outcome and pH, haemoglobin and phosphate concentrations as predictors, only pH had a significant influence on 2,3-DPG concentrations (r=0.6, P=0.011). With haemoglobin concentration there was a trend towards significance (r=0.45, P= 0.066), whereas the effect of phosphate concentrations was clearly not significant (r=0.24, P=0.346).
Patient in vivo P50 values-correlation with 2,3-DPG concentrations
There was no correlation between 2,3-DPG concentrations and in vivo P50, either with or without temperature correction (Figure 1 , r 2 0.08). There was also a consistent underestimation of in vivo P50 by corresponding standard P50 values, particularly at low 2,3-DPG concentrations (Figure 1) .
DISCUSSION
We were able to show that the mean venous 2,3-DPG concentration was low in a group of ICU patients with a broad range of diagnoses and a high severity of illness score. It is thus likely that low 2,3-DPG concentrations were the explanation for the low mean standard P50 values reported both by Myburgh 4 and by Huang 5 . No patient in the current study was hypoxaemic. This, together with the tendency to acidaemia rather than alkalaemia distinguishes our cohort from the unusually hypoxaemic and alkalaemic patients with ARDS reported by Clerbaux 3 . Since prolonged severe hypoxaemia and alkalaemia can both increase 2,3-DPG concentrations 17 , it also probably explains why the mean 2,3-DPG concentration was not elevated as in the Belgian patients.
Of the factors known to alter 2,3-DPG concentrations, only pH was clearly influential in our study. 481 
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Anaesthesia and Intensive Care, Vol. 29, No. 5, October 2001 4 found strong correlations between standard P50 and both arterial pH and base excess. Our finding of reduced 2,3-DPG concentrations in comparison with those of normal, healthy controls might thus be attributed to a tendency to acidaemia in the patient group. Acidaemia reduces 2,3-DPG concentrations in two ways-by suppression of phosphofructokinase, thus reducing production of fructose-1, 6-biphosphate (a glycolytic precursor of 2,3-DPG), and by simultaneously enhancing 2,3-DPG phosphatase activity causing accelerated degradation of 2,3-DPG 15 . By reducing 2,3-DPG concentrations over time, acidaemia reduces both standard P50 and in vivo P50, but because of the Bohr effect there is a simultaneous tendency to increase in vivo P50 15 . With prolonged acidaemia it is possible for these opposing influences on in vivo P50 to cancel each other out, leaving no net alteration 18 . From our data such a process was probably operative in the patient group, since there was no evident relationship between 2,3-DPG concentrations and in vivo P50 values in these individuals (Figure 1) .
Serum phosphate concentrations are reported to influence 2,3-DPG concentrations 17, 19 , with hypophosphataemia causing a reduction and hyperphosphataemia an elevation in concentrations. We could not confirm such a relationship, perhaps because so few (three) of the measurements were markedly abnormal. Furthermore, despite the overall anaemia of the group and the known tendency of anaemia to increase 2,3-DPG 15 , haemoglobin concentrations failed to show a statistically significant influence on 2,3-DPG concentrations. This is another indication that pH was the overriding influence on 2,3-DPG concentrations in these patients.
In similar fashion, no association between serum phosphate concentrations and the standard P50 (and by implication 2,3-DPG concentrations) was identified in the studies of Myburgh 4 or Huang 5 , nor was Myburgh able to detect an influence of haemoglobin concentration on standard P50 4 . It therefore seems unlikely that serum phosphate or blood haemoglobin concentrations are important causes of altered 2,3-DPG concentrations or P50 in the majority of critically ill patients.
To our knowledge, this is the first evaluation of in vivo P50 in critical illness. To calculate the in vivo P50 values we employed the Oxygen Status Algorithm of Siggaard-Andersen. A problem to be overcome was the inaccuracy of the algorithm if haemoglobinoxygen saturation values ≥ 97% are used 16 . Since saturations exceeded 97% in 75% of the arterial specimens, we chose instead to calculate in vivo P50 by direct substitution of measured 2,3-DPG concentrations along with the corresponding acid-base parameters. With this approach, haemoglobin-oxygen saturation values were not required and potential inaccuracy was avoided.
If anything, patient in vivo P50 values were high rather than low, despite the overall reduction in 2,3-DPG concentrations. To illustrate, with normal input parameters of a temperature of 37°C , PCO 2 of 40 mmHg, pH of 7.4 and a 2,3-DPG concentration of 5.0 mmol/l, the P50 is calculated to be 26.5 mmHg 16 . By comparison we found the mean in vivo P50 in the twenty critically ill patients to be 28.0±1.3 mmHg, and even without temperature correction, this value was close to normal at 26.4±2.6 mmHg.
The consistent underestimation of in vivo P50 by standard P50 (Figure 1) , particularly in the patients with low 2,3-DPG concentrations, confirms the inadequacy of standard P50 as an index of haemoglobin-oxygen affinity in critical illness. Even though in vivo P50 values were calculated from measured 2,3-DPG concentrations, there was no correlation between these two variables. This can only stem from the strong influence of acid-base balance on haemoglobin-oxygen affinity in these patients. Our data thus indicate that critically ill patients with low 2,3-DPG concentrations (and thus low standard P50) are no more likely to have increased haemoglobin-oxygen affinity and consequent reduction in tissue oxygen availability than patients with normal or high 2,3-DPG concentrations (Figure 1) .
From our data we conclude that the mean 2,3-DPG concentration was lower in a broad group of nonhypoxaemic critically ill patients than in normal controls. The only identifiable cause for this reduction was acidaemia, presumably due to effects on enzymes of the Embden Meyerhof pathway. There was no correlation between 2,3-DPG concentrations and the in vivo P50, probably because acidaemia simultaneously increases tissue oxygen availability by reducing haemoglobin-oxygen affinity. Our data cannot be extrapolated to patients suffering from severe and prolonged hypoxaemia, in whom current evidence suggests that 2,3-DPG concentrations are raised 3 .
